socalTECH

MARCH 5, 2012

Irvine-based SMC Networks , the developer of cable gateway and other networking hardware, announced today that it has named John Edmund Sweeney as VP of Technology. Sweeney joins the company from set-top box maker Scientific-Atlanta/Cisco Systems, and also served at Honeywell, Inc. READ MORE>>.

Networking 133

Networking Edmunds Technology Report 133

socalTECH

NOVEMBER 9, 2012

Edmunds was also one of the companies. NastyGal is just one of a number of fashion-meets-technology startups to emerge in Los Angeles, which. has long been home to both technology and fashion--but, based on its trajectory, looks to be one of the fastest growing. big requirements for development, release, and QA engineers.

Technical Review 279

Technical Review Company Companies Southern California 279

socalTECH

APRIL 13, 2011

Glendale-based FutureLogic , a supplier of thermal printers and technology, said yesterday that it has expanded in South America. The firm named Emilio Machado as head of New Business Development in South America as part of the move. FutureLogic said that Machado will report to John Edmunds, VP International Markets.

Edmunds 100

Edmunds Glendale Report Marketing 100

socalTECH

NOVEMBER 15, 2012

If you're a web publisher, or even a brand developing your own outreach to customers through a newsletter or microsite, how do you efficiently gather and curate all of the news and information out there? We found that aggregation technology was very keyword driven, and relevancy was not that strong.

Web 237

Web Newsletter Content Startup 237

socalTECH

JULY 17, 2019

For today's interview, we talked with Gina Callari , the COO of RelayCars (www.relaycars.com), a unit of a larger company called EVOX Images, which has developed virtual reality (VR) and augmented reality (AR) software which lets consumers view and experience automobiles using things like Magic Leap and even just smartphone.

Sales 124

Sales Research Content Edmunds 124

Xconomy

AUGUST 7, 2020

Big Pharma companies are focusing on vaccine development and a slew of biotechs are testing compounds, previously intended for a wide range of indications, as potential COVID-19 treatments. The novel coronavirus has driven the pharmaceutical industry to upend its research priorities. billion merger in the digital health sector.

Research 80

Research Develop Development Edmunds 80